Dermatology · Washington, DC
NPI
1588800916
Since 2009
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2150 Pennsylvania Ave NW
Washington, DC, 20037
Phone (202) 741-2600
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
8,378 services
Medicare patients, 2024
354
Average age 74
Drug cost, 2024
$699K
913 prescriptions
Company payments, 2025
$639K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam Friedman was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 6,000 times for 22 patients. In total Adam Friedman billed 8,378 services in 36 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 6,000 | 22 | $1.34 | $8,055 |
| 99214 Office E&M - Established | Office | 241 | 186 | $99.99 | $24K |
| 17003 Destruction Skin Lesion | Office | 218 | 57 | $5.86 | $1,277 |
| 99213 Office E&M - Established | Office | 172 | 123 | $71.62 | $12K |
| 96900 Skin | Office | 151 | 14 | $21.28 | $3,213 |
| 11102 Skin Biopsy | Office | 111 | 86 | $81.90 | $9,091 |
| 17000 Destruction Skin Lesion | Office | 96 | 80 | $42.07 | $4,038 |
| 96372 Injection Administration | Office | 42 | 11 | $10.63 | $446 |
| 17110 Destruction Skin Lesion | Office | 40 | 36 | $98.43 | $3,937 |
| 96573 Skin | Office | 33 | 29 | $198.49 | $6,550 |
| 99204 Office E&M - New | Office | 30 | 30 | $125.88 | $3,776 |
| 11103 Skin Biopsy | Office | 29 | 25 | $45.43 | $1,317 |
| 99203 Office E&M - New | Office | 27 | 27 | $74.23 | $2,004 |
| 11900 Skin | Office | 25 | 18 | $43.83 | $1,096 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 21 | 19 | $12.05 | $253 |
By year: 2022 $94K for 2,054 services; 2023 $135K for 4,224 services; 2024 $141K for 8,378 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adam Friedman prescribed most often to Medicare patients was Clobetasol Propionate, with 78 prescriptions and refills. In total Adam Friedman wrote 913 Medicare prescriptions that cost $699K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 78 | 100 | 32 | $5,563 |
| Minoxidil Generic | 64 | 171 | 21 | $724 |
| Dutasteride Generic | 62 | 108 | 14 | $1,837 |
| Finasteride Generic | 59 | 118 | 17 | $597 |
| Hydroxychloroquine Sulfate Generic | 57 | 75 | Under 11 | $919 |
| Dupixent Pen Dupilumab | 49 | 56 | Under 11 | $217K |
| Gabapentin Generic | 48 | 59 | Under 11 | $552 |
| Halobetasol Propionate Generic | 40 | 43 | 12 | $2,132 |
| Doxycycline Hyclate Generic | 33 | 60 | 13 | $1,299 |
| Ammonium Lactate Generic | 31 | 46 | 14 | $699 |
| Fluorouracil Generic | 19 | 19 | 18 | $1,194 |
| Ketoconazole Generic | 15 | 28 | Under 11 | $234 |
| Finacea Azelaic Acid | 15 | 18 | Under 11 | $6,588 |
| Ciclopirox Generic | 14 | 18 | Under 11 | $638 |
| Levocetirizine Dihydrochloride Generic | 14 | 26 | Under 11 | $230 |
Brand drugs: 173 claims; generic drugs: 740 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam Friedman $639K ($639K in general payments such as food, travel and fees) from 31 companies. The largest payer was Genzyme Corporation with $130K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 40 | $130K |
| Regeneron Healthcare Solutions, Inc. REGN | 76 | $115K |
| Lilly USA, LLC LLY | 39 | $72K |
| Pfizer Inc. PFE | 33 | $70K |
| Galderma Laboratories, L.P. GALD.SW | 27 | $58K |
| UCB, Inc. UCB.BR | 46 | $43K |
| Novartis Pharmaceuticals Corporation NVS | 25 | $24K |
| Janssen Biotech, Inc. JNJ | 20 | $22K |
| Arcutis Biotherapeutics, Inc. ARQT | 14 | $20K |
| Incyte Corporation INCY | 30 | $17K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.